Condition
Philadelphia Chromosome Negative ALL clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Philadelphia Chromosome Negative ALL clinical trials that are recruiting, at sites in 2 countries (most in Mexico (1), China (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Low-dose venetoclax with itraconazole plus TACL chemotherapy for relapsed/refractory Philadelphia‑negative ALL
This trial tests whether adding low‑dose venetoclax (boosted with itraconazole) to a TACL chemotherapy regimen helps people with relapsed or refractory Philadelphia‑chromosome‑negative acute lymphoblastic leukemia achieve remission and get to stem cell transplant.
-
Combining chemotherapy with CAR-T cell therapy for newly diagnosed adult patients with Philadelphia Chromosome Negative ALL
This study is testing if combining CAR-T cell therapy with chemotherapy can help adults newly diagnosed with Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia feel better and live longer.
Related topics
Quick answers
How many Philadelphia Chromosome Negative ALL clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Mexico (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.